glp-1 agonist or antagonist Glucagon-like peptide-1 Video: Non-insulin injectable antidiabetic drugs

Neuro-ophthalmology merges the fields of neurology and ophthalmology, often dealing with complex systemic diseases that manifest in the vision system

However, people with underlying conditions like a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), or severe gastrointestinal disease should avoid semaglutide injections and consult medical professionals at a weight loss clinic for alternative options

Dietary patterns that support GLP-1 biology may also help people tolerate GLP-1 receptor agonist (GLP-1RA) therapy by reducing gastrointestinal side effects, which are a frequent reason for discontinuation in clinical practice

If NASH worsens, it can lead to severe liver scarring (cirrhosis) and even liver cancer

Dela, J.J